当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件19583条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Galantamine
DRUG FOR FURTHER PROCESSING
0591-3498
Actavis Pharma, Inc.
2008/12/15 0:00:00
GALANTAMIN
DRUG FOR FURTHER PROCESSING
24
0591-3498_
Guaifenesin
DRUG FOR FURTHER PROCESSING
0591-3638
Actavis Pharma, Inc.
2015/9/16 0:00:00
GUAIFENESI
DRUG FOR FURTHER PROCESSING
1200
0591-3638_
Guaifenesin and Pseudoephedrine HCl
DRUG FOR FURTHER PROCESSING
0591-3639
Actavis Pharma, Inc.
2015/5/27 0:00:00
GUAIFENESI
DRUG FOR FURTHER PROCESSING
0591-3639_
Guaifenesin and Pseudoephedrine HCl
DRUG FOR FURTHER PROCESSING
0591-3640
Actavis Pharma, Inc.
2015/5/27 0:00:00
GUAIFENESI
DRUG FOR FURTHER PROCESSING
0591-3640_
Guaifenesin and Dextromethorphan Hydrobromide
DRUG FOR FURTHER PROCESSING
0591-3641
Actavis Pharma, Inc.
2015/9/17 0:00:00
DEXTROMETH
DRUG FOR FURTHER PROCESSING
0591-3641_
Guaifenesin and Dextromethorphan Hydrobromide
DRUG FOR FURTHER PROCESSING
0591-3642
Actavis Pharma, Inc.
2015/9/17 0:00:00
DEXTROMETH
DRUG FOR FURTHER PROCESSING
0591-3642_
Nabumetone
DRUG FOR FURTHER PROCESSING
0591-3670
Actavis Pharma, Inc.
2011/6/13 0:00:00
NABUMETONE
DRUG FOR FURTHER PROCESSING
500
0591-3670_
Nabumetone
DRUG FOR FURTHER PROCESSING
0591-3671
Actavis Pharma, Inc.
2011/6/13 0:00:00
NABUMETONE
DRUG FOR FURTHER PROCESSING
750
0591-3671_
Nitrofurantoin
DRUG FOR FURTHER PROCESSING
0591-3684
Actavis Pharma, Inc.
2015/8/25 0:00:00
NITROFURAN
DRUG FOR FURTHER PROCESSING
25
0591-3684_
Nitrofurantoin
DRUG FOR FURTHER PROCESSING
0591-3685
Actavis Pharma, Inc.
2015/8/25 0:00:00
NITROFURAN
DRUG FOR FURTHER PROCESSING
50
0591-3685_
Nitrofurantoin
DRUG FOR FURTHER PROCESSING
0591-3686
Actavis Pharma, Inc.
2015/8/25 0:00:00
NITROFURAN
DRUG FOR FURTHER PROCESSING
100
0591-3686_
Ezetimibe
DRUG FOR FURTHER PROCESSING
0591-3713
Actavis Pharma, Inc.
2017/6/12 0:00:00
EZETIMIBE
DRUG FOR FURTHER PROCESSING
10
0591-3713_
solifenacin succinate
DRUG FOR FURTHER PROCESSING
0591-3795
Actavis Pharma, Inc.
2019/9/27 0:00:00
SOLIFENACI
DRUG FOR FURTHER PROCESSING
5
0591-3795_
solifenacin succinate
DRUG FOR FURTHER PROCESSING
0591-3796
Actavis Pharma, Inc.
2019/9/27 0:00:00
SOLIFENACI
DRUG FOR FURTHER PROCESSING
10
0591-3796_
Vigabatrin
DRUG FOR FURTHER PROCESSING
0591-3851
Actavis Pharma, Inc.
2019/2/6 0:00:00
VIGABATRIN
DRUG FOR FURTHER PROCESSING
500
0591-3851_
vigabatrin
DRUG FOR FURTHER PROCESSING
0591-3955
Actavis Pharma, Inc.
2018/4/23 0:00:00
VIGABATRIN
DRUG FOR FURTHER PROCESSING
50
0591-3955_
Celecoxib
DRUG FOR FURTHER PROCESSING
0591-3982
Actavis Pharma, Inc.
2015/3/12 0:00:00
CELECOXIB
DRUG FOR FURTHER PROCESSING
50
0591-3982_
Celecoxib
DRUG FOR FURTHER PROCESSING
0591-3983
Actavis Pharma, Inc.
2015/3/12 0:00:00
CELECOXIB
DRUG FOR FURTHER PROCESSING
100
0591-3983_
Celecoxib
DRUG FOR FURTHER PROCESSING
0591-3984
Actavis Pharma, Inc.
2015/3/12 0:00:00
CELECOXIB
DRUG FOR FURTHER PROCESSING
200
0591-3984_
Celecoxib
DRUG FOR FURTHER PROCESSING
0591-3985
Actavis Pharma, Inc.
2015/3/12 0:00:00
CELECOXIB
DRUG FOR FURTHER PROCESSING
400
0591-3985_
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3